Not every hazard comes with a warning sign. Many of these dangers are so common that people don’t think twice about them, ...

The annual District Fit gathering, now in its ninth year, highlights the city's rapidly evolving status as a hub for healthy ...

FDA approved AVLAYAH™ (tividenofusp alfa-eknm) for treatment of Hunter syndrome (MPS II) and as first medicine to leverage transferrin receptor ...

Full-Year 2026 Revenue Outlook -- Expected between $1.455 billion and $1.475 billion. Full-Year 2026 Adjusted EBITDA Outlook -- Expected between $310 million and $330 million, excluding specific Hatch ...

Henry Foster III, 55, is a Democrat and the incumbent San Diego City Council member representing District 4, and he is running for re-election. Foster, a Valencia Park native, was first elected to the ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Prebiotic Fiber, 10 Billion CFU Probiotics, Green Superfoods, Berberine, Adaptogens, and 90-Day Return Policy Explained ...

By David Bautz, PhD NASDAQ: CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Planning for Phase 3 Registration Trial ...

U.S. stock indexes closed lower, with the S&P 500 and Nasdaq Composite retreating from intraday record highs, as oil futures ...

Light (NASDAQ:LASR) reported what management called an “exceptional” first quarter of 2026, with revenue, margins, and ...